Categories Earnings, Health Care

Titan Pharmaceuticals, Inc. (TTNP): Q4 2019 Earnings Snapshot

Earnings Update by AlphaStreet

— Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in line with Wall Street expectation.

— Q4 revenue was flat at $1.2 million, vs. $920,000 expected.

— As at December 31, 2019, Titan had cash and cash equivalents of approximately $5.2 million.

— Launch of Sixmo may be delayed due to the impact of Covid-19.

— TTNP shares gained 4.4% during after-market trading hours.

Most Popular

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and

AMAT Stock: Is now the right time to invest in Applied Materials?

It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied

Here’s a look at Take-Two Interactive Software’s (TTWO) expectations for the coming year

Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top